Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Lung Cancer|October 10, 2006
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance statusRogerio C Lilenbaum, Rudolf M Huber, Joseph Treat, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6Paul J Hesketh, Rogerio C Lilenbaum, Kari Chansky, et al.Clinical Lung Cancer|May 11, 2013
Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortiumMichael A Samuels, Shravan Kandula, Tulay Koru-Sengul, et al.Clinical Lung Cancer|April 12, 2015
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2015
Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung CancerChristopher D Corso, Charles E Rutter, Henry S Park, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)Rogerio C Lilenbaum, James E Herndon, Marcy A List, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2Mauro Zukin, Carlos H Barrios, Jose Rodrigues Pereira, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapyThomas J Lynch, George R Blumenschein, Jeffrey A Engelman, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.Pageof 2